_id
690f36e0ccc777a4e85d179b
Ticker
BMNDF
Name
Biomind Labs Inc.
Exchange
PINK
Address
Building Ceibo Of. 002, Canelones, Uruguay
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.biomindlabs.com
Description
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine based formulation that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment; BMND06 is in Phase I clinical trial for treatment of morbid obesity; and BMDO9 is in Phase I clinical trial for treatment of Parkinson's disease. It is also developing preclinical drug candidates, including BMND02 for the treatment of fibromyalgia, BMND03 for the treatment of addictive disorders, BMND05 for the treatment of chronic pain, BMND05 for the treatment of inflammatory disorders, and BMND07 for the treatment of major depressive disorder. The company is headquartered in Canelones, Uruguay.
Last Close
0.114
Volume
1000
Current Price
0.114
Change
0.08779631255487522
Last Updated
2026-01-20T16:46:47.680Z
Image
data:image/webp;base64,UklGRkABAABXRUJQVlA4IDQBAACwCACdASpAAEAAPrVQoUunJKMhrhSZyOAWiUAaEFJYkBLAG8S/tuwwNIEy0aBwOBpAR87+iAef7fZ1iOaIt1oH0twckQYnoEr+TgLLWAAA/vlYQAUHGZffm2vmNIhf0dwuvzv0F543OK/la+Gx4criE7z5FSIZBXi+pdk94vbxzUwvWb7+N8cHv1VTZ48kztaK1uCTx6uZZdx+5381TVJ8MmOcugI6mwPF0OA2RUznhrf5mr1QoiN3YPyicxVORcHPJouJm8KJ0ULl7jPPFmmGQhmrcgg1R4iNQQE+LKJY9dcrTCmcLjBF5Qlj7ujZRiTUvXMBa3qBq37+YkL8P17+qt0D4pb57w3Cao81pi+Ce7dR5wfK2zAXxtlY+C36szfw+IvjgMCP42Wurr9rvR3pLUIAAA==
Ipo Date
-
Market Cap
10177871
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
86026
Operating Income
-86026
Interest Expense
19029
Pretax Income
-101616
Net Income
-101616
Eps
-0.0013099610344087405
Dividends Per Share
-
Shares Outstanding
77571773
Income Tax Expense
-
EBITDA
-82590
Operating Margin
-
Total Other Income Expense Net
-15590
Cash
36765
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
57715
Property Plant Equipment
0
Total Assets
57715
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1617738
Equity
-1560023
Bs_currency_symbol
USD
Depreciation
0
Change In Working Capital
46720
Cash From Operations
-39008
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
65269
Net Change In Cash
36453
Cf_currency_symbol
USD
PE
0
PB
-5.668622912610904
ROE
6.513750117786725
ROA
-176.06514770856796
FCF
-39008
Fcf Percent
-
Piotroski FScore
1
Health Score
28
Deep Value Investing Score
1
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
86026
Quarters > 0 > income Statement > operating Income
-86026
Quarters > 0 > income Statement > interest Expense
19029
Quarters > 0 > income Statement > pretax Income
-101616
Quarters > 0 > income Statement > net Income
-101616
Quarters > 0 > income Statement > eps
-0.0013099610344087405
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
77571773
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-82590
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-15590
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
36765
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
57715
Quarters > 0 > balance Sheet > property Plant Equipment
0
Quarters > 0 > balance Sheet > total Assets
57715
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1617738
Quarters > 0 > balance Sheet > equity
-1560023
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-101616
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
46720
Quarters > 0 > cash Flow > cash From Operations
-39008
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
65269
Quarters > 0 > cash Flow > net Change In Cash
36453
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.0013099610344087405
Quarters > 0 > ratios > PB
-5.668622912610904
Quarters > 0 > ratios > ROE
6.513750117786725
Quarters > 0 > ratios > ROA
-176.06514770856796
Quarters > 0 > ratios > FCF
-39008
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
92535
Quarters > 1 > income Statement > operating Income
-92535
Quarters > 1 > income Statement > interest Expense
18090
Quarters > 1 > income Statement > pretax Income
-116542
Quarters > 1 > income Statement > net Income
-116542
Quarters > 1 > income Statement > eps
-0.0015023763863177397
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
77571773
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-98452
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-24007
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
275
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
21225
Quarters > 1 > balance Sheet > property Plant Equipment
0
Quarters > 1 > balance Sheet > total Assets
21225
Quarters > 1 > balance Sheet > payables
559915
Quarters > 1 > balance Sheet > short Term Debt
648092
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1520038
Quarters > 1 > balance Sheet > equity
-1498813
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-116542
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
113982
Quarters > 1 > cash Flow > cash From Operations
19655
Quarters > 1 > cash Flow > capital Expenditures
3.32
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
375
Quarters > 1 > cash Flow > net Change In Cash
127
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.0015023763863177397
Quarters > 1 > ratios > PB
-5.900123712564543
Quarters > 1 > ratios > ROE
7.775619773780986
Quarters > 1 > ratios > ROA
-549.0789163722026
Quarters > 1 > ratios > FCF
19651.68
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
2223
Quarters > 2 > income Statement > gross Profit
-2223
Quarters > 2 > income Statement > operating Expenses
115316
Quarters > 2 > income Statement > operating Income
-115316
Quarters > 2 > income Statement > interest Expense
17604
Quarters > 2 > income Statement > pretax Income
-66900
Quarters > 2 > income Statement > net Income
-66765
Quarters > 2 > income Statement > eps
-0.0008606867861586714
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
77571773
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-47066
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
48416
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
148
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
21098
Quarters > 2 > balance Sheet > property Plant Equipment
0
Quarters > 2 > balance Sheet > total Assets
21098
Quarters > 2 > balance Sheet > payables
320669
Quarters > 2 > balance Sheet > short Term Debt
628538
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1383466
Quarters > 2 > balance Sheet > equity
-1362368
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-66765
Quarters > 2 > cash Flow > depreciation
2230
Quarters > 2 > cash Flow > change In Working Capital
113407
Quarters > 2 > cash Flow > cash From Operations
456
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
1
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.0008606867861586714
Quarters > 2 > ratios > PB
-6.491037753382345
Quarters > 2 > ratios > ROE
4.900658265608118
Quarters > 2 > ratios > ROA
-316.4517963788037
Quarters > 2 > ratios > FCF
456
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
28
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
1794
Quarters > 3 > income Statement > gross Profit
-1794
Quarters > 3 > income Statement > operating Expenses
94380
Quarters > 3 > income Statement > operating Income
-94380
Quarters > 3 > income Statement > interest Expense
191588
Quarters > 3 > income Statement > pretax Income
172265
Quarters > 3 > income Statement > net Income
172265
Quarters > 3 > income Statement > eps
0.0022221578673115115
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
77521495
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-15525
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
266645
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
147
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
21097
Quarters > 3 > balance Sheet > property Plant Equipment
20064
Quarters > 3 > balance Sheet > total Assets
41161
Quarters > 3 > balance Sheet > payables
447117
Quarters > 3 > balance Sheet > short Term Debt
670677
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1341353
Quarters > 3 > balance Sheet > equity
-1300192
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
172265
Quarters > 3 > cash Flow > depreciation
2230
Quarters > 3 > cash Flow > change In Working Capital
-4543
Quarters > 3 > cash Flow > cash From Operations
-102683
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
84739
Quarters > 3 > cash Flow > net Change In Cash
-9970
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.0022221578673115115
Quarters > 3 > ratios > PB
-6.797034922534519
Quarters > 3 > ratios > ROE
-13.249197041667692
Quarters > 3 > ratios > ROA
418.51509924443036
Quarters > 3 > ratios > FCF
-102683
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
47
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
8491
Annuals > 0 > income Statement > gross Profit
-8491
Annuals > 0 > income Statement > operating Expenses
395529
Annuals > 0 > income Statement > operating Income
-395529
Annuals > 0 > income Statement > interest Expense
31077
Annuals > 0 > income Statement > pretax Income
-260479
Annuals > 0 > income Statement > net Income
-260479
Annuals > 0 > income Statement > eps
-0.0034207616101243165
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
76146493
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-395529
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
135050
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
147
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
21097
Annuals > 0 > balance Sheet > property Plant Equipment
20064
Annuals > 0 > balance Sheet > total Assets
41161
Annuals > 0 > balance Sheet > payables
447117
Annuals > 0 > balance Sheet > short Term Debt
670677
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1341353
Annuals > 0 > balance Sheet > equity
-1300192
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-260479
Annuals > 0 > cash Flow > depreciation
8920
Annuals > 0 > cash Flow > change In Working Capital
47184
Annuals > 0 > cash Flow > cash From Operations
-354425
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
302249
Annuals > 0 > cash Flow > net Change In Cash
-24118
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.0034207616101243165
Annuals > 0 > ratios > PB
-6.676475629753145
Annuals > 0 > ratios > ROE
20.033887302798355
Annuals > 0 > ratios > ROA
-632.8296202716164
Annuals > 0 > ratios > FCF
-354425
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
15424
Annuals > 1 > income Statement > gross Profit
-15424
Annuals > 1 > income Statement > operating Expenses
994182
Annuals > 1 > income Statement > operating Income
-976279
Annuals > 1 > income Statement > interest Expense
164346
Annuals > 1 > income Statement > pretax Income
-1192451
Annuals > 1 > income Statement > net Income
-1214000
Annuals > 1 > income Statement > eps
-0.016238195874909715
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
74762000
Annuals > 1 > income Statement > income Tax Expense
-2
Annuals > 1 > income Statement > EBITDA
-1035000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-216172
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
24140
Annuals > 1 > balance Sheet > short Term Investments
125
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
45215
Annuals > 1 > balance Sheet > property Plant Equipment
28835
Annuals > 1 > balance Sheet > total Assets
74199
Annuals > 1 > balance Sheet > payables
561241
Annuals > 1 > balance Sheet > short Term Debt
735542
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1506319
Annuals > 1 > balance Sheet > equity
-1424792
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-1214319
Annuals > 1 > cash Flow > depreciation
15147
Annuals > 1 > cash Flow > change In Working Capital
229410
Annuals > 1 > cash Flow > cash From Operations
-765926
Annuals > 1 > cash Flow > capital Expenditures
0.26
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
762451
Annuals > 1 > cash Flow > net Change In Cash
-1891
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.016238195874909715
Annuals > 1 > ratios > PB
-5.98183313774923
Annuals > 1 > ratios > ROE
85.20541945771734
Annuals > 1 > ratios > ROA
-1636.140648795806
Annuals > 1 > ratios > FCF
-765926.26
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
42489
Annuals > 2 > income Statement > gross Profit
-42489
Annuals > 2 > income Statement > operating Expenses
2891000
Annuals > 2 > income Statement > operating Income
-2891000
Annuals > 2 > income Statement > interest Expense
1307
Annuals > 2 > income Statement > pretax Income
-2986000
Annuals > 2 > income Statement > net Income
-2986000
Annuals > 2 > income Statement > eps
-0.039940076509456676
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
74762000
Annuals > 2 > income Statement > income Tax Expense
1361
Annuals > 2 > income Statement > EBITDA
-2891000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-94918
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
26156
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
44933
Annuals > 2 > balance Sheet > property Plant Equipment
44131
Annuals > 2 > balance Sheet > total Assets
89064
Annuals > 2 > balance Sheet > payables
328560
Annuals > 2 > balance Sheet > short Term Debt
8162
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
336722
Annuals > 2 > balance Sheet > equity
-247658
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2985503
Annuals > 2 > cash Flow > depreciation
44243
Annuals > 2 > cash Flow > change In Working Capital
186078
Annuals > 2 > cash Flow > cash From Operations
-2150889
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-38520
Annuals > 2 > cash Flow > net Change In Cash
-2247507
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.039940076509456676
Annuals > 2 > ratios > PB
-34.4138610503194
Annuals > 2 > ratios > ROE
1205.6949502943576
Annuals > 2 > ratios > ROA
-3352.645288781101
Annuals > 2 > ratios > FCF
-2150889
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
28071
Annuals > 3 > income Statement > gross Profit
-28071
Annuals > 3 > income Statement > operating Expenses
3399346
Annuals > 3 > income Statement > operating Income
-3399000
Annuals > 3 > income Statement > interest Expense
3680
Annuals > 3 > income Statement > pretax Income
-4332000
Annuals > 3 > income Statement > net Income
-4332000
Annuals > 3 > income Statement > eps
-0.060116569525395507
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
72060000
Annuals > 3 > income Statement > income Tax Expense
3713
Annuals > 3 > income Statement > EBITDA
-3399000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-933000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2273663
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
2439591
Annuals > 3 > balance Sheet > property Plant Equipment
88374
Annuals > 3 > balance Sheet > total Assets
2527965
Annuals > 3 > balance Sheet > payables
289633
Annuals > 3 > balance Sheet > short Term Debt
70064
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
334954
Annuals > 3 > balance Sheet > equity
2193011
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4332360
Annuals > 3 > cash Flow > depreciation
28321
Annuals > 3 > cash Flow > change In Working Capital
-104211
Annuals > 3 > cash Flow > cash From Operations
-2122619
Annuals > 3 > cash Flow > capital Expenditures
44591
Annuals > 3 > cash Flow > cash From Investing
-44341
Annuals > 3 > cash Flow > cash From Financing
4470862
Annuals > 3 > cash Flow > net Change In Cash
2273663
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.060116569525395507
Annuals > 3 > ratios > PB
3.7459182831276268
Annuals > 3 > ratios > ROE
-197.53662886323872
Annuals > 3 > ratios > ROA
-171.36313200538774
Annuals > 3 > ratios > FCF
-2167210
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.0013099610344087405
Valuation > metrics > PB
-5.668622912610904
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
6.513750117786725
Profitability > metrics > ROA
-176.06514770856796
Profitability > final Score
28
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-4.52078406642493
Risk > final Score
12
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
70
Prev Profitabilities > 0
31
Prev Profitabilities > 1
25
Prev Profitabilities > 2
45
Prev Risks > 0
10
Prev Risks > 1
4
Prev Risks > 2
28
Prev Liquidities > 0
11
Prev Liquidities > 1
11
Prev Liquidities > 2
11
Updated At
2026-01-20T21:30:24.709Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0013
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0015
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0009
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.0022
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0004
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0028
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0025
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0036
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0017
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0048
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0058
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0071
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0124
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-06-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0109
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-03-31
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0103
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2021-12-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0159
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-09-30
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0361
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-06-30
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.4709
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-03-31
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0052
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2020-12-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0048
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-09-30
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0032
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-06-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0054
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-03-31
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0053
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2019-12-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0241
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-09-30
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.0007
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-06-30
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0077
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-03-31
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.0046
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2018-12-31
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.0001
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-09-30
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.0047
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-06-30
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.0007
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-03-31
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
0.0038
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2017-12-31
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.0033
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-09-30
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.0112
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-06-30
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.0038
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-03-31
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.0023
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2016-12-31
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
0.0009
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-09-30
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.0015
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-06-30
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.0014
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-03-31
Earnings History > 38 > report Date
2016-03-31
Earnings History > 38 > date
2016-03-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.0022
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2015-12-31
Earnings History > 39 > report Date
2015-12-31
Earnings History > 39 > date
2015-12-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.0044
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2015-09-30
Earnings History > 40 > report Date
2015-09-30
Earnings History > 40 > date
2015-09-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.002
Earnings History > 40 > eps Estimate
-
Earnings History > 40 > eps Difference
0
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-06-30
Earnings History > 41 > report Date
2015-06-30
Earnings History > 41 > date
2015-06-30
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.006
Earnings History > 41 > eps Estimate
-
Earnings History > 41 > eps Difference
0
Earnings History > 41 > surprise Percent
-
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine based formulation that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment; BMND06 is in Phase I clinical trial for treatment of morbid obesity; and BMDO9 is in Phase I clinical trial for treatment of Parkinson's disease. It is also developing preclinical drug candidates, including BMND02 for the treatment of fibromyalgia, BMND03 for the treatment of addictive disorders, BMND05 for the treatment of chronic pain, BMND05 for the treatment of inflammatory disorders, and BMND07 for the treatment of major depressive disorder. The company is headquartered in Canelones, Uruguay.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Biomind Labs Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0013
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.